Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG in severe COVID-19 pneumonia
IRCT20151227025726N20Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of immune globulin in coronavirus pneumonia (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Need for mechanical ventilation, Need for admission to critical care unit and 1 more. Started Jul 2020; status: completed.
02
Drugs
immune globulin
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on IRCT20151227025726N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151227025726N20.